Venue: Hauser Forum, The Entrepreneurship Centre, 3 Charles Babbage Road, Cambridge CB3 0GT
Infection has become one of the toughest problems in the medical world. As bacteria become more resistant to drugs, materials and surfaces are seen as complementary measures for infection control and management. “Drug-free Antibacterial Technology for Medical Applications” will review advances and needs in these technologies from business, clinical and research perspectives.
You can register for the meeting at https://www.cambridgenetwork.co.uk/events/lucideon/
Aspects covered include;
- Clinical Need and Issues faced by drug-free antibacterial technology
- Antibacterial Materials; Synthetic Polymers, Natural Polymers, Glasses and Ceramics.
- Developing products and novel technologies for medical devices and cosmetic, pharmaceutical and medical applications
- Networks and support in anti-bacterial technology.
Supported in part through HyMedPoly, there will be an opportunity to view posters on the project and to meet members of the project’s researcher cohort.
Clinical Need and Issues faced by drug-free antibacterial technology, Dr Jochen Salber, UMC Knappschaftskrankenhaus Bochum, Germany
New Concepts of Drug-free Antibacterial Science Technology, Dr Xiang Zhang , Lucideon Limited, Cambridge, UK
Biomimetic strategies in the design of antibacterial synthetic polymers, Prof. Gianluca Ciardelli, Politecnico di Torino, Turin, Italy
Antibacterial Natural Polymers, Prof. Ipsita Roy, University of Westminster
The development of antibacterial inorganic materials and their potential for new medical technologies, Dr Mark Cresswell, Lucideon Limited, Stoke on Trent, UK
Developing functionalized biopolymers products for cosmetic, pharmaceutical, biological and medical applications, Dr Hongyun Tai, Blafar Limited, Dublin, Ireland
Digital and Modelling Informed Approaches to Antibacterial Product Development, Prof Atul Bhaskar, University of Southampton
Novel antimicrobial technology for medical devices; BALI, IBIZA and PRINT-AID, Dr S.A.J. Zaat, Academic Medical Center, Amsterdam, Netherlands
The National Biofilms Innovation Centre (NBIC), Prof. Jeremy Webb, University of Southampton